PL3137059T3 - Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut - Google Patents

Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut

Info

Publication number
PL3137059T3
PL3137059T3 PL15724823T PL15724823T PL3137059T3 PL 3137059 T3 PL3137059 T3 PL 3137059T3 PL 15724823 T PL15724823 T PL 15724823T PL 15724823 T PL15724823 T PL 15724823T PL 3137059 T3 PL3137059 T3 PL 3137059T3
Authority
PL
Poland
Prior art keywords
containing liquid
liquid pharmaceutical
pharmaceutical suspensions
making bismuth
bismuth
Prior art date
Application number
PL15724823T
Other languages
English (en)
Inventor
Steven Ray Gilbert
Edward Paul V Fitch
Derrick Ho
Daniel Jerome. WHITE JR
Adam Michael. TUNIS
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL3137059T3 publication Critical patent/PL3137059T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15724823T 2014-04-29 2015-04-29 Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut PL3137059T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461985653P 2014-04-29 2014-04-29
PCT/US2015/028215 WO2015168241A1 (en) 2014-04-29 2015-04-29 Method for making bismuth-containing liquid pharmaceutical suspensions
EP15724823.8A EP3137059B1 (en) 2014-04-29 2015-04-29 Method for making bismuth-containing liquid pharmaceutical suspensions

Publications (1)

Publication Number Publication Date
PL3137059T3 true PL3137059T3 (pl) 2018-10-31

Family

ID=53267574

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15724823T PL3137059T3 (pl) 2014-04-29 2015-04-29 Metoda wytwarzania płynnych zawiesin farmaceutycznych zawierających bizmut

Country Status (10)

Country Link
US (3) US9486436B2 (pl)
EP (1) EP3137059B1 (pl)
CN (1) CN106255495B (pl)
AU (1) AU2015253187B2 (pl)
CA (2) CA2943420C (pl)
ES (1) ES2682210T3 (pl)
MX (1) MX370908B (pl)
PL (1) PL3137059T3 (pl)
RU (1) RU2694530C2 (pl)
WO (1) WO2015168241A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016138746A (ru) 2014-04-23 2018-05-24 Дзе Проктер Энд Гэмбл Компани Циклогексанкарбоксамид с охлаждающими свойствами
RU2694530C2 (ru) * 2014-04-29 2019-07-16 Дзе Проктер Энд Гэмбл Компани Способ изготовления жидких фармацевтических суспензий, содержащих висмут
RU2676261C2 (ru) * 2014-04-29 2018-12-27 Дзе Проктер Энд Гэмбл Компани Жидкие фармацевтические суспензии, содержащие висмут
WO2017037706A1 (en) * 2015-08-31 2017-03-09 Zelikman Vadim An appartus for dispensing a predefined dosage form
US20200179411A1 (en) 2017-08-25 2020-06-11 L. Perrigo Company Pharmaceutical suspensions for bismuth subsalicylates
FR3089392B1 (fr) * 2018-12-07 2021-12-31 Oenotropic Innovation Utilisation d’un polysaccharide et d’un compose soufre pour la mise en suspension de particules dans une composition liquide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1269987A (en) 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
US4801454A (en) * 1986-07-17 1989-01-31 The Proctor & Gamble Company Processes for making colored pharmaceutical compositions
US5013560A (en) 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
US6482865B1 (en) 2000-04-12 2002-11-19 Gastropal Partners Method for preparing colloidal solution of bismuth sodium tartrate
US6712496B2 (en) * 2001-07-26 2004-03-30 The Procter & Gamble Company Auger fed mixer apparatus and method of using
US7135197B2 (en) 2002-02-04 2006-11-14 Pharmacia Corporation Stable pharmaceutical composition useful for treating gastrointestinal disorders
WO2003074086A1 (fr) 2002-03-04 2003-09-12 Medrx Co., Ltd. Matrice liquide a transfert de phase in vivo, et preparations liquides orales
GB0507167D0 (en) * 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
ATE530630T1 (de) 2006-03-22 2011-11-15 Procter & Gamble Flüssige behandlungszusammensetzung
US20080008814A1 (en) * 2006-06-22 2008-01-10 Philip Henry Jackson Acidified Protein Beverages Containing Suspended Particulates and Methods of Making Same
US20080227892A1 (en) 2007-03-13 2008-09-18 Van Der Wielen Maarten Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners
WO2009001323A2 (en) * 2007-06-28 2008-12-31 The Procter & Gamble Company Apparatus and method for mixing of fluids by producing shear and/or cavitation, and components for such an apparatus
US8394752B2 (en) 2008-12-18 2013-03-12 The Procter & Gamble Company Pearlescent agent slurry for liquid treatment composition
RU2694530C2 (ru) * 2014-04-29 2019-07-16 Дзе Проктер Энд Гэмбл Компани Способ изготовления жидких фармацевтических суспензий, содержащих висмут
RU2676261C2 (ru) * 2014-04-29 2018-12-27 Дзе Проктер Энд Гэмбл Компани Жидкие фармацевтические суспензии, содержащие висмут

Also Published As

Publication number Publication date
CN106255495B (zh) 2019-10-22
US10034888B2 (en) 2018-07-31
RU2016137537A (ru) 2018-05-29
EP3137059B1 (en) 2018-05-23
CN106255495A (zh) 2016-12-21
CA2943420A1 (en) 2015-11-05
CA3041501A1 (en) 2015-11-05
RU2694530C2 (ru) 2019-07-16
AU2015253187A1 (en) 2016-10-13
RU2016137537A3 (pl) 2018-05-29
US10532063B2 (en) 2020-01-14
BR112016025072A2 (pt) 2017-08-15
MX370908B (es) 2020-01-08
US20170027964A1 (en) 2017-02-02
CA3041501C (en) 2020-09-22
WO2015168241A1 (en) 2015-11-05
EP3137059A1 (en) 2017-03-08
ES2682210T3 (es) 2018-09-19
CA2943420C (en) 2019-06-25
BR112016025072A8 (pt) 2021-07-06
US20180303852A1 (en) 2018-10-25
AU2015253187B2 (en) 2017-10-05
US9486436B2 (en) 2016-11-08
MX2016013884A (es) 2017-02-02
US20150306061A1 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
GB201517013D0 (en) Differential headtracking apparatus
LT3171891T (lt) Būdas
GB201406151D0 (en) Method
GB201418159D0 (en) Method
GB201408119D0 (en) Method
GB201417042D0 (en) Method
GB201410262D0 (en) Novel method
IL250488B (en) Method for forming lanthanide nanoparticles
EP3171179A4 (en) Liquid stirring method
GB201421664D0 (en) Method
PL3227023T3 (pl) Sposób wytwarzania kropel
GB201419900D0 (en) Method
PL3196196T3 (pl) Sposób wytwarzania kalcobutrolu
EP3241807A4 (en) Method for purifying liquid
GB201403568D0 (en) Dense media deparation method
GB201403470D0 (en) Method
PT3380668T (pt) Dispositivo de moagem
SG11201607948VA (en) Filtering apparatus
PT3169844T (pt) Método para prevenir a formação de incrustação
EP3315287A4 (en) Container manufacturing apparatus
PT3046590T (pt) Processo para preparar um preparado farmacêutico líquido
GB201418626D0 (en) Method
PL3137056T3 (pl) Ciekłe zawiesiny farmaceutyczne zawierające bizmut
SG10201503704QA (en) Method for mixing fluids
GB201409234D0 (en) Method